Naisarg Gamit

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Combination Therapy

Cognitive Decline

Top Venues

Bioengineering (Basel, Switzerland)

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Naisarg Gamit, Manasi Patil, Soumya B Sundrappa, S Mohana Sundaram, Gautam Sethi, Arun Dharmarajan, Sudha Warrier
Mesenchymal stem cell-derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs. Drug development research (2023)
Manasi Patil, Naisarg Gamit, Arun Dharmarajan, Gautam Sethi, Sudha Warrier
Identification of a Novel Wnt Antagonist Based Therapeutic and Diagnostic Target for Alzheimer's Disease Using a Stem Cell-Derived Model. Bioengineering (Basel, Switzerland) 10 (2) (2023)
Manasi Patil, Naisarg Gamit, Arun Dharmarajan, Gautam Sethi, Sudha Warrier
Identification of a Novel Wnt Antagonist Based Therapeutic and Diagnostic Target for Alzheimer's Disease Using a Stem Cell-Derived Model. Bioengineering (Basel, Switzerland) 10 (2) (2023)
Lavanya Varier, S Mohana Sundaram, Naisarg Gamit, Sudha Warrier
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4. Cancers 15 (4) (2023)
Lavanya Varier, S Mohana Sundaram, Naisarg Gamit, Sudha Warrier
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4. Cancers 15 (4) (2023)
Manasi Patil, Naisarg Gamit, Arun Dharmarajan, Gautam Sethi, Sudha Warrier
Identification of a Novel Wnt Antagonist Based Therapeutic and Diagnostic Target for Alzheimer's Disease Using a Stem Cell-Derived Model. Bioengineering (Basel, Switzerland) 10 (2) (2023)
Lavanya Varier, S Mohana Sundaram, Naisarg Gamit, Sudha Warrier
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4. Cancers 15 (4) (2023)